Tenax Therapeutics Presents at 2026 Cantor Global Healthcare Conference

What Happened
Tenax Therapeutics, Inc. (TENX) filed a Form 8-K (Regulation FD disclosure, Item 7.01) reporting that it presented at the Cantor Global Healthcare Conference on September 9, 2026 at 8:35 a.m. ET. A condensed presentation was used at the conference and the full investor presentation dated September 9, 2026 was posted on the company website and attached to the 8-K as Exhibit 99.1. The company stated that website content is not incorporated by reference into the filing and that it does not undertake any obligation to update the presentation.

Key Details

• Presentation delivered: September 9, 2026 at 8:35 a.m. ET (Cantor Global Healthcare Conference).
• Slide deck: Full investor presentation dated September 9, 2026 attached as Exhibit 99.1 to the 8-K.
• Disclosure type: Regulation FD disclosure reported under Item 7.01 of Form 8-K.
• Company note: Website content not incorporated into the filing; no obligation to update or amend the presentation.

Why It Matters
This filing gives investors access to the company’s public investor presentation and corporate messaging presented at a major healthcare conference. While not a financial report or earnings release, the slide deck may include updates on strategy, clinical programs, timelines or upcoming milestones that investors can review. Because the company did not incorporate website content into the filing and disclaimed any update obligation, investors should rely on the attached Exhibit 99.1 for the company’s current disclosures and watch for future filings for formal updates.